Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Brigitte Keon in G-Protein-Coupled Receptor Research
Introduction: Brigitte Keon, based in Castro Valley, California, is an inventive mind specializing in the field of biochemistry and pharmacology. With significant contributions to the understanding and modulation of G-protein-coupled receptors (GPCRs), her work stands out in the realm of drug discovery and screening methodologies.
Latest Patents: Brigitte Keon holds a patent for her invention titled "Fragment Complementation Assays for G-Protein-Coupled Receptors and Their Signaling Pathways." This innovative methodology provides a comprehensive approach to screening candidate drugs, compound libraries, or biological extracts aimed at identifying activators or inhibitors of GPCRs and their associated pathways. The process involves constructing assays using fluorescent protein fragment complementation to examine one or more steps in GPCR signaling, effectively testing candidate substances and yielding significant results in drug discovery.
Career Highlights: Keon has made notable strides in her career, particularly through her role at Odyssey Thera Inc., where she focuses on advancing therapeutic approaches via innovative drug screening techniques. Her commitment to research and development has paved the way for new insights into GPCR functions and their implications in various biological processes.
Collaborations: During her career, Brigitte Keon has collaborated with esteemed colleagues such as John K Westwick and Marnie L MacDonald. These partnerships highlight her collaborative spirit and further enhance the potential for groundbreaking advancements in her field.
Conclusion: As an inventor, Brigitte Keon has significantly contributed to innovations in the pharmaceutical industry, particularly surrounding G-protein-coupled receptors. Her patent not only exemplifies her inventive prowess but also underscores the ongoing need for innovative screening methods in drug discovery. With her work continuing to influence the field, Keon's contributions are invaluable in the quest for therapeutic advancements.